2.5. In Vitro Phosphatase Assay

KK Keon Woo Khim
SC Sun Sil Choi
HJ Hyun-Jun Jang
YL Yo Han Lee
EL Eujin Lee
JH Ji-Min Hyun
HE Hye-Jin Eom
SY Sora Yoon
JC Jeong-Won Choi
TP Tae-Eun Park
DN Dougu Nam
JC Jang Hyun Choi
request Request a Protocol
ask Ask a question
Favorite

PPM1A human recombinant and active ERK1 were purchased from Prospec (Ness-Ziona, Israel) and SignalChem (Richmond, British Columbia, Canada), respectively. Glutathione S-transferase (GST)-fused PPARγ was incubated with active ERK1 in kinase assay buffer (25 mmol/L Tris-HCl, pH 7.5, 5 mmol/L β-glycerophosphate, 2 mmol/L DTT, 0.1mmol/L Na3VO4, 10 mmol/L MgCl2) containing 20 μmol/L ATP for 20 min at 30 °C. Then, purified phosphorylated GST-fused PPARγ was added into PPM1A human recombinant containing PPM1A phosphatase buffer [38] and incubated 30 min at 30 °C. To check the effect of catalytic inactive mutants of PPM1A (R174G and D239N) in dephosphorylation of PPARγ, HEK-293 cells were transfected with mutants expressing vector. Immunopurified PPM1As were incubated with phosphorylated GST-fused PPARγ in PPM1A phosphatase buffer for 30 min at 30 °C. All reactions were terminated by the addition of protein sample buffer. Phosphorylation of PPARγ was analyzed by SDS-PAGE with phospho-specific antibody against PPARγ at Ser273, anti-GST, or PPM1A antibodies.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A